PVP-Guided Decongestive Therapy in HF 2
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-99
SponsorBaşakşehir Çam & Sakura City Hospital
About this trial
The investigators hypothesize that a simple assessment of peripheral venous pressure (PVP) will better predict the diuretic need and long-term outcomes (all cause mortality, all cause rehospitalization, emergency department visits) compared to standard evaluation.
Eligibility criteria
Qualifiers
Hospitalization for heart failure (de novo or decompensated chronic heart failure) irrespective of left ventricular ejection fraction
Age 18-99
Accept to participate
Disqualifiers
A prior history of upper extremity venous disease
Serum creatinine ≥ 3.5 mg/dL
Severe stenotic valvular disease
Hypertrophic obstructive cardiomyopathy
Trial design
Treatments tested in this trial
- Diuretic therapy
Treatment groups
650 Participants
are divided into 2 treatment groupsSponsors and collaborators
Başakşehir Çam & Sakura City Hospital
Lead sponsor
Ankara Etlik City Hospital
Collaborator
Akdeniz University
Collaborator
Bağcılar Training and Research Hospital
Collaborator
Bakırçay University, Faculty of Medicine
Collaborator
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
Collaborator
Eskişehir City Hospital
Collaborator
İdil State Hospital
Collaborator
Kafkas University Health Research and Application Hospital
Collaborator
Kutahya Health Sciences University
Collaborator
Istanbul Mehmet Akif Ersoy Educational and Training Hospital
Collaborator
Pazarcık State Hospital
Collaborator
Tokat Gaziosmanpasa University
Collaborator
Trakya University
Collaborator
Ataturk University
Collaborator
Source ClinicalTrials.gov